Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2020 Feb;20(1):e5-e12.
doi: 10.18295/squmj.2020.20.01.002. Epub 2020 Mar 9.

Association between Bioactive Molecules in Breast Milk and Type 1 Diabetes Mellitus

Affiliations
Review

Association between Bioactive Molecules in Breast Milk and Type 1 Diabetes Mellitus

Tajudeen Yahaya et al. Sultan Qaboos Univ Med J. 2020 Feb.

Abstract

The association between breastfeeding and type 1 diabetes mellitus (T1DM) is controversial. However, several recent studies have established a link between these two factors, necessitating a need to review this subject to raise public awareness. Current research indicates that breast milk contains a variety of bioactive substances including immunoglobulins, oligosaccharides, insulin, lactoferrin, lysozyme, cytokines, epidermal growth factors, leukocytes, nucleotides, beneficial bacteria and vitamins. Such substances strengthen the breastfeeding infant's immune system, both directly, by increasing gut microbiota diversity and attacking harmful bacteria and pro-inflammatory molecules, and indirectly, by increasing thymus performance. Accordingly, a lack of or inadequate breastfeeding may predispose infants to several autoimmune disorders, including T1DM. Nursing mothers and caregivers are therefore advised to follow optimal breastfeeding practices prior to introducing complementary foods.

Keywords: Autoimmune Diseases; Breastfeeding; Immunoglobulins; Oligosaccharides; Review Literature; Type 1 Diabetes Mellitus.

PubMed Disclaimer

References

    1. Kalathi D, James S, Zaidi R. Diagnosis and management of type 1 diabetes mellitus. Clin Pharm. 2018;10:1. doi: 10.1211/CP.2018.20205044. - DOI
    1. Thomas NJ, Jones SE, Weedon MN, Weedon MN, Shields BM, Oram RA, et al. Frequency and phenotype of type 1 diabetes in the first six decades of life: A cross-sectional, genetically stratified survival analysis from UK Biobank. Lancet Diabetes Endocrinol. 2018;6:122–9. doi: 10.1016/S2213-8587(17)30362-5. - DOI - PMC - PubMed
    1. Soltesz G, Patterson CC, Dahlquist G EURODIAB Study Group. Worldwide childhood type 1 diabetes incidence: What can we learn from epidemiology? Pediatr Diabetes. 2007;8:6–14. doi: 10.1111/j.1399-5448.2007.00280.x. - DOI - PubMed
    1. Redondo MJ, Libman I, Cheng P, Kollman C, Tosur M, Gal RL, et al. Racial/ethnic minority youth with recent-onset type 1 diabetes have poor prognostic factors. Diabetes Care. 2018;41:1017–24. doi: 10.2337/dc17-2335. - DOI - PubMed
    1. Burrack AL, Martinov T, Fife BT. T cell-mediated beta cell destruction: Autoimmunity and alloimmunity in the context of type 1 diabetes. Front Endocrinol (Lausanne) 2017;8:343. doi: 10.3389/fendo.2017.00343. - DOI - PMC - PubMed

Substances

LinkOut - more resources